Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Global X S&P 500 Catholic Values ETF | CATH | Nov 21, 2024 | 72.35 | +0.65 |
Global X Super Dividend ETF | DIV | Nov 21, 2024 | 19.09 | +1.49 |
Global X SuperDividend Alternatives ETF | ALTY | Nov 21, 2024 | 11.97 | +0.25 |
Global X SuperDividend REIT ETF | SRET | Nov 21, 2024 | 21.10 | +0.38 |
Global X Superincome Preferred | SPFF | Nov 21, 2024 | 9.67 | +0.52 |
Global X Telemedicine & Digital Health ETF | EDOC | Nov 21, 2024 | 9.72 | +0.83 |
Global-E Online | GLBE | Nov 21, 2024 | 49.89 | +4.24 |
GLOBALFOUNDRIES | GFS | Nov 21, 2024 | 42.00 | +0.82 |
Globalink Investment SPAC | GLLI | Nov 21, 2024 | 11.44 | +0.18 |
Globalstar | GSAT | Nov 21, 2024 | 1.77 | +3.51 |
Globant | GLOB | Nov 21, 2024 | 222.69 | +3.24 |
Globavend | GVH | Nov 21, 2024 | 0.69 | -2.82 |
Globe Life | GL | Nov 21, 2024 | 108.99 | +0.21 |
Globus Maritime | GLBS | Nov 21, 2024 | 1.31 | -4.38 |
Globus Medical A | GMED | Nov 21, 2024 | 84.91 | +1.58 |
GlucoTrack | GCTK | Nov 21, 2024 | 0.25 | -6.09 |
GlycoMimetics | GLYC | Nov 21, 2024 | 0.32 | -3.03 |
GMS | GMS | Nov 21, 2024 | 99.10 | +0.81 |
GNMA Bond Ishares | GNMA | Nov 21, 2024 | 43.30 | 0.00 |
GoDaddy A | GDDY | Nov 21, 2024 | 193.01 | +1.52 |
Gogo | GOGO | Nov 21, 2024 | 8.28 | +6.98 |
Gogoro | GGR | Nov 21, 2024 | 0.48 | +4.31 |
GoHealth A | GOCO | Nov 21, 2024 | 11.50 | +1.77 |
Golar Lng | GLNG | Nov 21, 2024 | 36.86 | +2.45 |
Gold and Silver Sector Index | XAU | Nov 21, 2024 | 153.41 | +1.16 |
Gold Fields ADR | GFI | Nov 21, 2024 | 15.07 | +0.87 |
Gold Miners Bear 3X Direxion | DUST | Nov 21, 2024 | 56.63 | -2.38 |
Gold Miners Bull 3X Direxion | NUGT | Nov 21, 2024 | 44.40 | +2.30 |
Gold Miners ETF Market Vectors | GDX | Nov 21, 2024 | 38.14 | +1.11 |
Gold Resource | GORO | Nov 21, 2024 | 0.15 | +6.92 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.